Dr. Dmitry Kostyushev
is the head of the Laboratory of Genetic Technologies at Sechenov University in
Moscow, Russia. He has a Master’s degree from Sechenov University, a Doctorate and
Post-Doctorate from the Central Research Institute of Epidemiology, and a
Habilitation from the National Medical Research Center for Tuberculosis and
Infectious Diseases. Dr. Kostyushev’s main research interests include using
CRISPR/Cas systems to destroy the hepatitis B virus, as well as understanding
the biology of hepatitis B and D viruses to identify new therapeutic targets.
He is particularly interested in developing new techniques for packaging and
delivering CRISPR/Cas systems in vivo.
Dr. Dmitry Kostyushev
is the head of the Laboratory of Genetic Technologies at Sechenov University in
Moscow, Russia. He has a Master’s degree from Sechenov University, a Doctorate and
Post-Doctorate from the Central Research Institute of Epidemiology, and a
Habilitation from the National Medical Research Center for Tuberculosis and
Infectious Diseases. Dr. Kostyushev’s main research interests include using
CRISPR/Cas systems to destroy the hepatitis B virus, as well as understanding
the biology of hepatitis B and D viruses to identify new therapeutic targets.
He is particularly interested in developing new techniques for packaging and
delivering CRISPR/Cas systems in vivo.